Last reviewed · How we verify

NCT04979039

Heart Rate Variability to Predict Hypotension Following Spinal Anesthesia in Cesarean Delivery

Completed Last updated 27 January 2025
What this trial tests

trial testing analgesia nociception index (ANI) monitoring in Cesarean Section in 50 participants. Completed in 28 December 2024.

Timeline
1 August 2021
Primary endpoint
30 June 2023
28 December 2024

Quick facts

Lead sponsorSeoul National University Bundang Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 August 2021
Primary completion30 June 2023
Estimated completion28 December 2024
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Bundang Hospital

Who can join

20 and older, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on the patient's heart rate variability, the analgesia nociception index (ANI) measures the activity of the autonomic nervous system and the sympathetic/parasympathetic nervous system and expresses it as a numerical value through a specific algorithm. The investigators will analyze it and see if it has the ability to predict severe hypotension following spinal anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04979039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing